ES358505A1 - Un dispositivo combinado de sustentacion y propulsion para embarcaciones maritimas. - Google Patents

Un dispositivo combinado de sustentacion y propulsion para embarcaciones maritimas.

Info

Publication number
ES358505A1
ES358505A1 ES358505A ES358505A ES358505A1 ES 358505 A1 ES358505 A1 ES 358505A1 ES 358505 A ES358505 A ES 358505A ES 358505 A ES358505 A ES 358505A ES 358505 A1 ES358505 A1 ES 358505A1
Authority
ES
Spain
Prior art keywords
nylon
mixtures
sustained release
release tablet
tablet coating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES358505A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SIXTEN ENGLESSON TEKNISK KONSULT
Original Assignee
SIXTEN ENGLESSON TEKNISK KONSULT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SIXTEN ENGLESSON TEKNISK KONSULT filed Critical SIXTEN ENGLESSON TEKNISK KONSULT
Publication of ES358505A1 publication Critical patent/ES358505A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
ES358505A 1967-09-04 1968-09-25 Un dispositivo combinado de sustentacion y propulsion para embarcaciones maritimas. Expired ES358505A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE1219667A SE324859B (no) 1967-09-04 1967-09-04

Publications (1)

Publication Number Publication Date
ES358505A1 true ES358505A1 (es) 1970-04-16

Family

ID=20295314

Family Applications (1)

Application Number Title Priority Date Filing Date
ES358505A Expired ES358505A1 (es) 1967-09-04 1968-09-25 Un dispositivo combinado de sustentacion y propulsion para embarcaciones maritimas.

Country Status (7)

Country Link
AT (1) AT280478B (no)
BE (1) BE720383A (no)
ES (1) ES358505A1 (no)
FR (1) FR8105M (no)
GB (1) GB1186990A (no)
NL (1) NL6812365A (no)
SE (1) SE324859B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU174057B (hu) * 1976-09-17 1979-10-28 Richter Gedeon Vegyeszet Sostav dlja pokrytij obespechivajuhhij uregulirovannuju otdachy aktivnogo vehhestva biologicheski aktivnykh preparatov i sposob poluchenija takikh preparatov s uregulirovannoj otdachej aktivnogo vehhestva
EP0211991B1 (en) * 1982-07-08 1989-10-25 Ab Leo Substained release tablets and method for preparation thereof
GB8322007D0 (en) * 1983-08-16 1983-09-21 Wellcome Found Pharmaceutical delivery system
USRE33994E (en) * 1983-08-16 1992-07-14 Burroughs Wellcome Co. Pharmaceutical delivery system
EP0467488B1 (en) * 1984-08-17 1995-10-11 The Wellcome Foundation Limited Composition for the controlled discharge of an active ingredient
US5178868A (en) * 1988-10-26 1993-01-12 Kabi Pharmacia Aktiebolaq Dosage form
WO2000021925A1 (fr) * 1998-10-09 2000-04-20 Ajinomoto Co., Inc. Derives de la cysteine

Also Published As

Publication number Publication date
GB1186990A (en) 1970-04-08
AT280478B (de) 1970-04-10
BE720383A (no) 1969-02-17
FR8105M (no) 1970-07-27
SE324859B (no) 1970-06-15
NL6812365A (no) 1969-03-06

Similar Documents

Publication Publication Date Title
DK0477333T3 (da) Farmaceutiske præparater
DE3686936D1 (de) Am zielorgan wirkendes enterales abgabesystem.
FI86373B (fi) Belaeggning foer en farmaceutiskt tablett med foerdroejd effekt och foerfarande foer framstaellning av en tablett.
ES358505A1 (es) Un dispositivo combinado de sustentacion y propulsion para embarcaciones maritimas.
NL155264B (nl) Werkwijze voor de bereiding van een in water onoplosbaar chelaat van een biologisch werkzaam aminozuur, zuuramide of aminoglycoside, alsmede een geheel of gedeeltelijk uit zo'n onoplosbaar chelaat bestaand gevormd voortbrengsel.
DE3367324D1 (en) Pharmaceutical products in sustained-release form, and their preparation process
BE755924A (fr) Derives d'acide pyrazole-4-acetique, leur procede de preparation et medicaments en contenant
GB1210968A (en) Improvements in or relating to the treatment of gastric ailments
Elsmore Saccharine aversion induced by delta-9-tetrahydrocannabinol: Effects of repeated doses prior to pairing with saccharine.
GB1391746A (en) Stimulative composition and process for its production
ES265597A1 (es) Un metodo para la preparaciën de un nuevo y util derivado del antibiëtico kanamicina
IE38235L (en) Combatting swine dysentery
GB1263839A (en) A novel aminoethanesulfonic acid
Cooper et al. Plasma-level studies of chlorpromazine following the administration of chlorpromazine hydrochloride and chlorpromazine embonate in chronic schizophrenics.
GB1019111A (en) Salts of 5-amino-isoindoline
GB1182320A (en) Dihydroorotic and Salts
Shore et al. Administration of bronchodilator to young children.
GB1300486A (en) Compositions for the treatment of respiratory ailments in man
GB1110397A (en) Ephedrine composition
GB1254125A (en) Pharmaceutical composition suitable for the treatment of certain vascular diseases
GB1284884A (en) A new insoluble salt of kanamycin
TH17624A (th) สูตรผสมทางสัตวแพทย์
Kondrashkova et al. Changed RNA content of cortical neurons caused by Frenolon.
DK504186D0 (da) Legeme indeholdende en overtrukket kerne
TAMURA et al. Studies on the Antidotal Action of Drugs Part 3 Effects of Vitamin C conjoined Pharmaceuticals on High-and Low-temperature Stresses